Malawi is On a Roll Against Rotavirus

“Very, very encouraging indeed” were the results of a rotavirus vaccine rollout in Malawi, according to the country’s head of health services.

Introduced in Malawi in 2012, the monovalent rotavirus vaccine (RV1) cut deaths from infant diarrhea by more than a third, found researchers from the University of Liverpool, University College London, and the Johns Hopkins Bloomberg School of Public Health. The findings lend new leverage to those who want the vaccine included in national immunization programs. Rotavirus is the chief cause of severe diarrhea and kills around 1,300 children a day, mostly in sub-Saharan Africa.

The study, published in the Lancet Global Health, found that the vaccine’s success rate in Malawi was similar to that in middle-income countries.

The Guardian

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top